RAPPORT ANNUEL2021
Chiffres
Subsides
Divers fonds et programmes de soutien permettent à l'ASSM – souvent en collaboration avec des fondations privées – d'encourager la relève scientifique et la recherche. Lorsque l’affectation des fonds n’est pas définie dans le cadre d’un legs, ceux-ci sont destinés à des domaines de recherche importants pour la médecine et le système de santé, mais encore peu établis.
Informations relatives à toutes les possibilités d’encouragement sur assm.chSubsides MD-PhD
Julien Angelillo, GenèveDeciphering the cross-talk between innate lymphoid cells and tumor-associated lymphatic vessels to improve anti-tumor immunity
|
CHF 146'692 |
Louis-Emmanuel Chriqui, LausanneVascular and immune impact of photodynamic therapy combined to immune checkpoint inhibition in malignant pleural mesothelioma: insights from an intravital imaging model
|
CHF 191'553 |
Morgane Decollogny, BernTargeting the niche of drug-tolerant tumor-repopulating cells to eradicate residual disease in triple-negative breast cancer
|
CHF 189’902 |
Manuel Egle, BernCardiac graft preservation and evaluation in transplantation with donation after circulatory death
|
CHF 189’902 |
Corinne Eicher, ZürichLocal sleep deprivation by closed-loop acoustic stimulation in depression: an experimental study of an innovative treatment approach
|
CHF 189'902 |
Felix Gerber, BaselGenerating evidence to improve access to early initiation of antiretroviral therapy in persons living with HIV in resource-limited settings
|
CHF 188'250 |
Tim Jonas Hallenberger, BaselThe role of early minimally invasive endoscopic surgery in spontaneous supratentorial intracerebral haemorrhage
|
CHF 188’250 |
Sarah Jungius, BaselSHP2 as a mediator of MAPK activation in myeloproliferative neoplasms: molecular mechanism and translational potential
|
CHF 188’250 |
Benedict Morin, BaselMechanisms of intracellular persistence of Staphylococcus aureus in human infection
|
CHF 188'250 |
Simon Schading, ZürichQuantitative and functional MRI investigation of the neurodegeneration associated with spinal cord injury in neuraxis
|
CHF 189'902 |
Ramon Stäger, ZürichUnravelling the cellular and molecular mechanisms of epithelial skin cancer development through multimodal single cell and spatial analysis
|
CHF 179'352 |
Katia Steinfeld, LausanneLifetime changes in visual processing associated with mild myopia
|
CHF 191'553 |
Young Talents in Clinical Research 2020
En raison de la pandémie de Covid-19, le délai de soumission des requêtes 2020 a été reporté de six mois. Ces subsides ayant été attribués en mai 2021, à l'issue du processus d'évaluation, ils apparaissent dans ce rapport annuel avec les subsides de la mise au concours 2021.
Dr Cihan Atila, BaselBeginner Grant: Circulating oxytocin changes in response to the oxytocin system stimulator MDMA in patients with Diabetes insipidus and healthy controls – the OxyMA-Study |
CHF 75'000 |
Dr Maria Boesing, LiestalBeginner Grant: Inhaled Aviptadil for the prevention of COVID-19 related ARDS |
CHF 72'412 |
Dr Sebastian Christ, ZürichBeginner Grant: Radio-oncological treatment of long-term glioblastoma survivors |
CHF 72'219 |
Dr Sonja Häckel, BernBeginner Grant: Surgical treatment of thoracolumbar incomplete burst fractures in patients without neurological symptoms: 360°-fusion versus posterior instrumentation with an additional vertebral body stent |
CHF 75'000 |
Dr Naomi Franziska Lange, BernBeginner Grant: Improving non-invasive assessment of advanced fibrotic MAFLD in diabetic patients |
CHF 73'660 |
Dr Sophia Lengsfeld, BaselBeginner Grant: Effects of Glucagon-Like Peptide-1 Analogs on Sexuality – the DESIRE study |
CHF 75'000 |
Dr Victor Frank Mergen, ZürichBeginner Grant: Optimizing cardiovascular risk prediction and success of transcatheter valve replacement with a new computed tomography technology |
CHF 72'283 |
Dr Jeanne Moor, BernBeginner Grant: Sex-specific association of pharmacotherapy dosage with clinical outcomes in participants of the BEAT-AF and Swiss-AF cohorts |
CHF 73'126 |
Dr Seraina Netzer, BernBeginner Grant: Association between hyponatremia and mortality and readmission in multimorbid older adults: a prospective cohort study |
CHF 71'308 |
Dr Bernhard Matthias Siepen, BernBeginner Grant: Deciphering outcomes in intracerebral haemorrhage associated with different types of oral anticoagulants |
CHF 74'000 |
Dr Stefanos Voglis, ZürichBeginner Grant: Exploring new biomarkers for therapy-response and clinical outcomes in brain metastases by in-depth characterization of the tumor microenvironment using imaging mass cytometry |
CHF 73'508 |
Dr Martina Zangger, BernBeginner Grant: Tackling potentially inappropriate prescriptions in Swiss primary care: sustainability and spillover effect of an eHealth solution for general practitioners and patients with polypharmacy |
CHF 73'500 |
Dr Martina Göldlin, BernProject Grant: What is the role of small vessel disease dynamics in the prognosis of intracerebral haemorrhage? A prospective MRI-cohort study (MRI-PRO-SVD) |
CHF 79'450 |
Dr Miro Emanuel Räber, ZürichProject Grant: Interleukin-2 modulated B cell homeostasis in systemic lupus erythematosus |
CHF 80'000 |
Young Talents in Clinical Research 2021
Dr Maiwand Ahmadsei, ZürichBeginner Grant: Towards a better understanding of imaging-based radiomics biomarkers by association with high-dimensional molecular analysis in malignant melanoma |
CHF 72'699 |
Dr Julia Flammer, BaselBeginner Grant: Characterization of IgA+ B cells in Glioblastoma multiforme – the Chance GBM study |
CHF 75'000 |
Dr Cecilia Friedrichs-Maeder, BernBeginner Grant: Pharmacological control of cortical excitability in epilepsy |
CHF 75'000 |
Dr Nicolas Gürtler, BaselBeginner Grant: Can continuous infusion coupled with therapeutic drug monitoring improve flucloxacillin target attainment compared to standard intermittent bolus dosing in patients with complicated Staphylococcus aureus infections? A randomized, controlled interventional trial |
CHF 75'000 |
Dr Oussama Habra, BernBeginner Grant: Artificial intelligence to detect optic disc abnormalities from infrared images of the ocular fundus |
CHF 75'000 |
Dr Sarah Hösli, ZürichBeginner Grant: Analyzing the effects of rotation and translation on perceived direction of self-motion using a motion simulator |
CHF 75'000 |
Dr Antonia Klein, BernBeginner Grant: Neuromodulatory treatment approach with transcranial alternating current stimulation for the Visual Snow Syndrome |
CHF 75'000 |
Dr Giulia Rathmes, ZürichBeginner Grant: Personalized insulin dosing: Retrospective analysis and machine learning prediction using electronic health records (EHRs) |
CHF 73'088 |
Dr Dominik Sager, ZürichBeginner Grant: Cardiac Positron Emission Tomography for Personalized Management of Patients with Coronary Artery Disease |
CHF 74'738 |
Dr Mirah Stuber, BernBeginner Grant: Central nervous system medication and risk of hospital admission in older multimorbid adults: a prospective cohort study |
CHF 70'830 |
Dr Paulina Sypniewska-El Khoury, GenèveBeginner Grant: Enhanced vs. standard pain management in patients at risk for persistent postoperative pain: a pragmatic, randomized controlled trial |
CHF 64'410 |
Dr Miranda Visini, BernBeginner Grant: The voice as a tool to detect recurrence of laryngeal cancer |
CHF 39'235 |
Dr Jacqueline Wyss, BernBeginner Grant: Impact of a low carbohydrate diet on the small intestinal microbiota |
CHF 75'000 |
Dr Marc-Antoine Bornet, LausanneProject Grant: Will to live and its relationship to life-sustaining treatment preferences, healthcare use and the wish to die among older nursing home residents |
CHF 80'000 |
Fonds Helmut Hartweg
Il n’y a pas eu de mise au concours du Fonds Helmut Hartweg en 2021 en raison de rendements boursiers insuffisants.
Fonds Käthe Zingg-Schwichtenberg (Fonds KZS)
Mise au concours thématique sur l’accès aux soins médicaux et infirmiers en cas de pénurie des ressources
Prof. Nikola Biller-Andorno, ZürichJust allocation of scarce healthcare resources during and beyond a pandemic: The case of triage |
CHF 48'000 |
Dr Rachel Rutz Voumard, LausanneSilent triage and cognitive biases during the COVID-19 pandemic and beyond |
CHF 75'700 |
PD Dr Tenzin Wangmo, BaselDecision making in times of scarce resources: A mixed-method study |
CHF 146'636 |
Fonds Théodore Ott
Il n’y a pas eu de mise au concours du Fonds Théodore Ott en 2021 en raison de rendements boursiers insuffisants.
Swiss Personalized Health Network
À la demande de la Confédération, l’ASSM dirige la mise en œuvre de l’initiative «Swiss Personalized Health Network» (SPHN) en collaboration avec le SIB Institut suisse de bioinformatique. Le SPHN contribue au développement, à l’implémentation et à la validation d’une infrastructure coordonnée, afin de rendre les données de santé interopérables et partageables pour la recherche en Suisse.
Une deuxième mise au concours publiée en 2021 s'est focalisée sur les «National Data Streams (NDS)» et soutiendra des consortiums multidisciplinaires qui investissent dans le développement d'une infrastructure de données durable. Les attributions pour les NDS n'auront lieu qu'au printemps 2022 et n'apparaissent donc pas dans le rapport annuel 2021.
Informations concernant les instruments d’encouragement spécifiques sur sphn.chÉtudes de cohortes
Comptes annuels
Les comptes annuels détaillés sont publiés sur le site internet de l’ASSM, dans la rubrique rapports annuels, en fin de page.
Vers le site internet
Bilan au 31 décembre 2021 – consolidé et détaillé |
$ Download |
Bilan au 31 décembre 2021 comparé avec l'année précédente – consolidé |
$ Download |
Compte d'exploitation 2021 – consolidé et détaillé |
$ Download |
Compte d'exploitation 2021 et de l'année précédente – consolidé |
$ Download |